| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/30/2009 | EP2138583A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 12/30/2009 | EP2138582A2 DNA and specific peptides or proteins of bacteria of the species neisseria meningitidis, methods for obtaining same and their biological applications |
| 12/30/2009 | EP2138511A1 HER3 as a determinant for the prognosis of melanoma |
| 12/30/2009 | EP2138510A1 Methods of generating antibodies against cytokines |
| 12/30/2009 | EP2138509A1 Tumor-associated peptide binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 12/30/2009 | EP2138508A1 Met agonists |
| 12/30/2009 | EP2138505A1 Method for producing soluble thrombomodulin of high purity |
| 12/30/2009 | EP2138195A2 IFBM's to promote attachment of target analytes |
| 12/30/2009 | EP2138192A1 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent |
| 12/30/2009 | EP2138158A1 Hair growth-inhibiting agent |
| 12/30/2009 | EP2137530A2 Antagonists of bitter taste receptors and uses thereof |
| 12/30/2009 | EP2137305A1 Engineered versions of cgtb (beta-1,3- galactosyltransferase) enzymes, with enhanced enzymatic properties |
| 12/30/2009 | EP2137302A2 Corn plants and seed enhanced for asparagine and protein |
| 12/30/2009 | EP2137292A1 Peptide mixture as wine stabiliser |
| 12/30/2009 | EP2137213A1 Methods and compositions for treating prostate cancer |
| 12/30/2009 | EP2137212A2 Mannoprotein liquid formulations |
| 12/30/2009 | EP2137204A1 Use of substrates as pharmacological chaperones |
| 12/30/2009 | EP2136836A2 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
| 12/30/2009 | EP2136831A2 Anti-angiogenic peptides |
| 12/30/2009 | EP2136824A1 Use of selected lactic acid bacteria for reducing atherosclerosis |
| 12/30/2009 | EP2049566B1 G-csf site-specific mono-conjugates |
| 12/30/2009 | EP1689432B1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 12/30/2009 | EP1618380B1 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION |
| 12/30/2009 | EP1530642B1 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 12/30/2009 | EP1504037B1 Ferritin fusion proteins for use in vaccines and other applications |
| 12/30/2009 | EP1438325B1 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 12/30/2009 | EP1409482B1 Dye-sulfenates for dual phototherapy |
| 12/30/2009 | EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/30/2009 | EP1066394B1 Novel basal endosperm transfer cell layer (betl) specific genes |
| 12/30/2009 | EP0804561B1 Regulated transcription of targeted genes and other biological events |
| 12/30/2009 | CN101616931A Smoothened多肽及使用方法 Smoothened polypeptide and methods of use |
| 12/30/2009 | CN101616930A Method of purification of hydrophobic proteins |
| 12/30/2009 | CN101616929A Peptide-complement conjugates |
| 12/30/2009 | CN101613705A Optimizing glycan processing in plants |
| 12/30/2009 | CN101613408A Method for separating and detecting whey proteins |
| 12/30/2009 | CN101613407A Modified trout protamine |
| 12/30/2009 | CN101613406A Genes and polypeptides relating to human colon cancers |
| 12/30/2009 | CN101613405A Genes and polypeptides relating to human colon cancers |
| 12/30/2009 | CN101613404A Method for separating and purifying green malt antimicrobial protein |
| 12/30/2009 | CN101613403A Method for preparing antimicrobial protein by using malt protein of barley |
| 12/30/2009 | CN101613402A Surface protein of streptococcus suis 2-type and preparation method and application thereof |
| 12/30/2009 | CN101613401A Nucleic acid enzyme surface protein of streptococcus suis 2-type and preparation method and application thereof |
| 12/30/2009 | CN101613400A Surface cytoderm protein of streptococcus suis 2-type and preparation method and application thereof |
| 12/30/2009 | CN101613399A Surface protein of streptococcus suis type-2, preparation method thereof and application |
| 12/30/2009 | CN101613398A Surface lipoprotein of streptococcus suis type-2, preparation method thereof and application |
| 12/30/2009 | CN101613397A Neisserial antigenic peptides |
| 12/30/2009 | CN100575493C Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100575360C Human liver regeneration enhancer with high activity and its preparation method |
| 12/30/2009 | CN100575359C Rana grahami boulenger antibiotic peptide and application thereof |
| 12/30/2009 | CA2729294A1 Toxin genes and methods for their use |
| 12/30/2009 | CA2729105A1 Attenuated pestivirus |
| 12/30/2009 | CA2729100A1 Methods for dosing an activin-actriia antagonist and monitoring of treated patients |
| 12/30/2009 | CA2729096A1 Methods for dosing an actriib antagonist and monitoring of treated patients |
| 12/30/2009 | CA2729054A1 Antagonists of actriib and uses for increasing red blood cell levels |
| 12/30/2009 | CA2728933A1 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 12/30/2009 | CA2728734A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof |
| 12/30/2009 | CA2728708A1 Factor viii muteins with reduced immunogenicity |
| 12/30/2009 | CA2728511A1 Sulfonamide compounds or salts thereof |
| 12/30/2009 | CA2728358A1 Storage-stable, functionally intact fibrinogen |
| 12/30/2009 | CA2728047A1 A process of purifying coagulation factor viii |
| 12/30/2009 | CA2728038A1 Novel immunoadjuvant flagellin-based compounds and use thereof |
| 12/30/2009 | CA2728012A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 12/30/2009 | CA2727310A1 Plants having enhanced yield-related traits and a method for making the same |
| 12/30/2009 | CA2726894A1 Therapeutic agents comprising elastin-like peptides |
| 12/30/2009 | CA2726465A1 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
| 12/30/2009 | CA2726054A1 Method of producing yeast biomass |
| 12/30/2009 | CA2714940A1 Her3 as a determinant for the prognosis of melanoma |
| 12/29/2009 | US7638694 Plants and seeds of hybrid corn variety CH944969 |
| 12/29/2009 | US7638693 Plants and seeds of hybrid corn variety CH120555 |
| 12/29/2009 | US7638692 Plants and seeds of hybrid corn variety CH538026 |
| 12/29/2009 | US7638681 Auxin transport proteins |
| 12/29/2009 | US7638679 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver. |
| 12/29/2009 | US7638618 Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
| 12/29/2009 | US7638614 Xenobiotic related induction of gene expression |
| 12/29/2009 | US7638613 For use in the treatment of paper pulp, stable over wide temperature and pH range |
| 12/29/2009 | US7638612 Compositions and methods for cDNA synthesis |
| 12/29/2009 | US7638608 Assay for the separation and quantification of hemagglutinin antigens |
| 12/29/2009 | US7638607 Urocortin proteins and uses thereof |
| 12/29/2009 | US7638604 Monoclonal antibodies against interleukin-22 |
| 12/29/2009 | US7638603 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis |
| 12/29/2009 | US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/29/2009 | US7638601 Transient receptor potential channel TRPM8 and its use |
| 12/29/2009 | US7638600 identification and characterization of environmental bacteriophages infecting Bacillus anthracis, including enzymes, fusion proteins |
| 12/29/2009 | US7638599 Enhance uptake of a pharmaceutically active agent into a cell, into or out of an intracellular compartment, and across a cell layer either directly or from a pharmaceutically active agent loaded particle; drug delivery |
| 12/29/2009 | US7638598 ErbB interface peptidomimetics and methods of use thereof |
| 12/29/2009 | US7638499 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/29/2009 | US7638498 Substances for preventing and treating autoimmune diseases |
| 12/29/2009 | US7638495 inhibiting precipitation; bone morphogenic proteins |
| 12/29/2009 | US7638494 G-type peptides to ameliorate atherosclerosis |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | US7638490 For treating anorexia or cachexia |
| 12/29/2009 | US7638489 Modulation of angiogenesis by Bartonella henselae |
| 12/29/2009 | US7638486 administering a first peptide comprising 10 to 50 amino acid residues and a second protein selected from bone morphogenic proteins, transforming growth, epidermal growth, epithelial cell growth, fibroblast growth, platelet derived growth or insulin-like growth factors, to enhance regeneration of bones |
| 12/29/2009 | US7638485 Modulating apoptosis |
| 12/29/2009 | US7638481 With vaccinia virus complement control protein, poxvirus encoded |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 12/29/2009 | US7638333 Anthrax vaccine |
| 12/29/2009 | US7638331 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |